---
figid: PMC9139317__cancers-14-02543-g005
figtitle: Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting
  in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma
organisms:
- Homo sapiens
- Mus musculus
- Bos taurus
- Agriosomyces longus
organisms_ner:
- Homo sapiens
- Mus musculus
- Bos taurus
pmcid: PMC9139317
filename: cancers-14-02543-g005.jpg
figlink: /pmc/articles/PMC9139317/figure/cancers-14-02543-f005/
number: F5
caption: 'Proposed Schematic. NRF2 activation promotes KYNU upregulation in lung adenocarcinoma,
  resulting in an immunosuppressive tumor microenvironment characterized by elevated
  tumor T-cell infiltration, including T regulatory TILs, and concordant increases
  in protein expression of immune checkpoint blockade-related PD1 and PD-L1 and poor
  prognosis. Abbreviations: AFMID—arylformamidase; AH—anthranilate hydroxylase; IDO—indoleamine
  2,3-dioxygenase; KEAP1—Kelch-like ECH-associated protein 1; KMO—kynurenine 3-monooxygenase;
  KYNU—kynureninase; NRF2—nuclear factor erythroid factor 2-related factor 2; PD1—programmed
  cell death protein-1; PDL1—programmed cell death ligand-1; sMAF—small musculoaponeurotic
  fibrosarcoma proteins; TDO—tryptophan 2,3-dioxygenase; Treg—regulatory T-cell.'
papertitle: Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting
  in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma.
reftext: Johannes F. Fahrmann, et al. Cancers (Basel). 2022 May;14(10):2543.
year: '2022'
doi: 10.3390/cancers14102543
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: NRF2 | KEAP1 | lung adenocarcinoma | metabolism | kynurenine pathway | kynureninase
  | immune suppression | prognostic marker
automl_pathway: 0.9374539
figid_alias: PMC9139317__F5
figtype: Figure
redirect_from: /figures/PMC9139317__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9139317__cancers-14-02543-g005.html
  '@type': Dataset
  description: 'Proposed Schematic. NRF2 activation promotes KYNU upregulation in
    lung adenocarcinoma, resulting in an immunosuppressive tumor microenvironment
    characterized by elevated tumor T-cell infiltration, including T regulatory TILs,
    and concordant increases in protein expression of immune checkpoint blockade-related
    PD1 and PD-L1 and poor prognosis. Abbreviations: AFMID—arylformamidase; AH—anthranilate
    hydroxylase; IDO—indoleamine 2,3-dioxygenase; KEAP1—Kelch-like ECH-associated
    protein 1; KMO—kynurenine 3-monooxygenase; KYNU—kynureninase; NRF2—nuclear factor
    erythroid factor 2-related factor 2; PD1—programmed cell death protein-1; PDL1—programmed
    cell death ligand-1; sMAF—small musculoaponeurotic fibrosarcoma proteins; TDO—tryptophan
    2,3-dioxygenase; Treg—regulatory T-cell.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GABPA
  - NFE2L2
  - IDO2
  - DLX3
  - TDO2
  - IDO1
  - AFMID
  - KYNU
  - KMO
  - PDCD1
  - RPL17
  - SNCA
  - SPATA2
  - RPL17-C18orf32
  - Nfe2l2
  - Ido2
  - Tdo2
  - Ido1
  - Afmid
  - Kynu
  - Kmo
  - Pdcd1
---
